AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iLIVER Article
PDF (258.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Practice revolution in local interventional therapy for liver metastases

Hongjun YuanaHongli YubYing GuanaWenjing WangbQiang YuaYinying Lub ( )Fengyong Liua( )
Department of Interventional Radiology, The 5th Medical Center of the PLA General Hospital, Beijing 100039, China
Comprehensive Liver Cancer Center, The 5th Medical Center of the PLA General Hospital, Beijing 100039, China
Show Author Information

Abstract

The treatment of liver metastases is undergoing a transformation from single-modality therapy to multimodal combination therapy, with local interventional treatments playing an increasingly important role. This review explores the synergistic effects between local interventional therapy and systemic treatment, the reconstruction of interventional therapy indications driven by advances in systemic treatment, and the impact of local interventional therapy on systemic treatment “switching” strategies. Through multidisciplinary collaboration and innovative interventional materials and techniques, local interventional therapy has evolved from a traditional palliative approach to become an essential component in the comprehensive treatment system for liver metastases.

References

【1】
【1】
 
 
iLIVER
Article number: 100164

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Yuan H, Yu H, Guan Y, et al. Practice revolution in local interventional therapy for liver metastases. iLIVER, 2025, 4(2): 100164. https://doi.org/10.1016/j.iliver.2025.100164

920

Views

59

Downloads

1

Crossref

0

Scopus

Received: 06 March 2025
Revised: 24 March 2025
Accepted: 07 April 2025
Published: 23 April 2025
© 2025 Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).